1.
Bassan R, Chiodini B, Zucchetti M, Lerede T, Cornelli P, Cortelazzo S, Barbui T. Short course infusional idarubicin plus intermittent cytarabine and etoposide for refractory hematologic malignancies: clinical and preliminary pharmacological results. Haematologica [Internet]. 1998Jan.1 [cited 2026Nov.7];83(1):27-3. Available from: https://haematologica.org/article/view/1035